Hyperosmolar hyperglycemic state differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Ahmed Younes (talk | contribs) No edit summary |
|||
(20 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | [[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Hyperosmolar_hyperglycemic_state]] | ||
{{ | {{CMG}}; {{AE}} {{HS}} | ||
==Overview== | ==Overview== | ||
The hyperosmolar hyperglycemic state must be differentiated from other conditions presenting with [[hyperglycemia]], [[hyperosmolarity]] or [[Altered mental status|an altered state of consciousness]]. The differentials include [[diabetes mellitus]], [[diabetic ketoacidosis]], [[impaired glucose tolerance]], and conditions causing [[altered sensorium]] such as [[CNS infections]] or [[stroke]]. All these conditions may be differentiated on the basis of history findings, clinical features, and laboratory abnormalities. | |||
==Differentiating Hyperosmolar Hyperglycemic State From Other Diseases== | |||
* Hyperosmolar hyperglycemic state must be differentiated from other diseases that present with [[hyperglycemia]], [[hyperosmolarity]], and [[altered state of consciousness]].<ref name="urlDiabetic Ketoacidosis: Evaluation and Treatment - American Family Physician">{{cite web |url=http://www.aafp.org/afp/2013/0301/p337.html |title=Diabetic Ketoacidosis: Evaluation and Treatment - American Family Physician |format= |work= |accessdate=}}</ref><ref name="pmid19564476">{{cite journal |vauthors=Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN |title=Hyperglycemic crises in adult patients with diabetes |journal=Diabetes Care |volume=32 |issue=7 |pages=1335–43 |year=2009 |pmid=19564476 |pmc=2699725 |doi=10.2337/dc09-9032 |url=}}</ref><ref name="pmid12668546">{{cite journal |vauthors=Chiasson JL, Aris-Jilwan N, Bélanger R, Bertrand S, Beauregard H, Ekoé JM, Fournier H, Havrankova J |title=Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state |journal=CMAJ |volume=168 |issue=7 |pages=859–66 |year=2003 |pmid=12668546 |pmc=151994 |doi= |url=}}</ref><ref name="pmid18975036">{{cite journal |vauthors=Joseph F, Anderson L, Goenka N, Vora J |title=Starvation-induced true diabetic euglycemic ketoacidosis in severe depression |journal=J Gen Intern Med |volume=24 |issue=1 |pages=129–31 |year=2009 |pmid=18975036 |pmc=2607495 |doi=10.1007/s11606-008-0829-0 |url=}}</ref><ref name="pmid6361416">{{cite journal |vauthors=Williams HE |title=Alcoholic hypoglycemia and ketoacidosis |journal=Med. Clin. North Am. |volume=68 |issue=1 |pages=33–8 |year=1984 |pmid=6361416 |doi= |url=}}</ref><ref name="pmid1554971">{{cite journal |vauthors=Durnas C, Cusack BJ |title=Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it |journal=Drugs Aging |volume=2 |issue=1 |pages=20–34 |year=1992 |pmid=1554971 |doi= |url=}}</ref><ref name="pmid10970986">{{cite journal |vauthors=Gokel Y, Paydas S, Koseoglu Z, Alparslan N, Seydaoglu G |title=Comparison of blood gas and acid-base measurements in arterial and venous blood samples in patients with uremic acidosis and diabetic ketoacidosis in the emergency room |journal=Am. J. Nephrol. |volume=20 |issue=4 |pages=319–23 |year=2000 |pmid=10970986 |doi=10.1159/000013607 |url=}}</ref><ref name="pmid9587792">{{cite journal |vauthors=Brinkmann B, Fechner G, Karger B, DuChesne A |title=Ketoacidosis and lactic acidosis--frequent causes of death in chronic alcoholics? |journal=Int. J. Legal Med. |volume=111 |issue=3 |pages=115–9 |year=1998 |pmid=9587792 |doi= |url=}}</ref> | |||
* Hyperosmolar hyperglycemic state should also be differentiated from conditions that can cause [[Focal neurologic signs|focal neurological signs]] or an [[Altered mental state|altered state of consciousness]] such as [[CNS infections]] and [[stroke]] by doing a simple [[Glucose test|finger stick glucose testing]]. | |||
{| | {| | ||
|- style="background: #4479BA; color: #FFFFFF; text-align: center;" | |- style="background: #4479BA; color: #FFFFFF; text-align: center;" | ||
! | !Diseases | ||
! | !Laboratory Findings | ||
! | !Physical Examination | ||
! | !History and Symptoms | ||
! | !Other Findings | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Diabetes mellitus]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Diabetes mellitus]] | ||
Line 40: | Line 23: | ||
** Random [[blood]] [[glucose]] level: >200 mg/dl | ** Random [[blood]] [[glucose]] level: >200 mg/dl | ||
** [[Glycosylated hemoglobin|HbA1C]]: >6.5 % | ** [[Glycosylated hemoglobin|HbA1C]]: >6.5 % | ||
* [[Urinalysis|Urinanalysis]] may show: | * [[Urinalysis|Urinanalysis]] may show: | ||
** [[Proteinuria]] | |||
* [[Proteinuria]] | ** [[Glucosuria]] | ||
* [[Glucosuria]] | * Positive [[antibodies]]: ([[Type 1 diabetes mellitus|Type 1 diabetes]]) | ||
** Anti-[[glutamic acid decarboxylase]] | |||
** Anti-[[Islets of Langerhans|islet cell]] | |||
([[Type 1 diabetes mellitus|Type 1 diabetes]]) | ** Anti-[[insulin]] | ||
* Anti-[[glutamic acid decarboxylase]] | |||
* Anti-[[Islets of Langerhans|islet cell]] | |||
* Anti-[[insulin]] | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Autonomic neuropathy|Autonomic]] and [[peripheral neuropathy]] | * [[Autonomic neuropathy|Autonomic]] and [[peripheral neuropathy]] | ||
* Decreased [[visual acuity]] ([[diabetic retinopathy]]) | * Decreased [[visual acuity]] ([[diabetic retinopathy]]) | ||
* [[Central obesity]][[Body mass index|(BMI]] >25 kg/m2) | |||
* [[Central obesity]] | |||
* [[Hypertension]] ([[Blood pressure]] >140/90 mmHg) | * [[Hypertension]] ([[Blood pressure]] >140/90 mmHg) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Family history]] of [[diabetes]] | * [[Family history]] of [[diabetes]] | ||
* [[Sedentary lifestyle]] | * [[Sedentary lifestyle]] | ||
* Stress | * Stress | ||
* [[Polyuria]] | * [[Polyuria]] | ||
* [[Polydipsia]] | * [[Polydipsia]] | ||
Line 78: | Line 47: | ||
* [[Polycystic ovary syndrome|Polycystic ovarian syndrome]] | * [[Polycystic ovary syndrome|Polycystic ovarian syndrome]] | ||
* [[Acanthosis nigricans]] | * [[Acanthosis nigricans]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Diabetic ketoacidosis]] | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Diabetic ketoacidosis]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Blood]] [[pH]] < 7.3 | * [[Blood]] [[pH]] < 7.3 | ||
* [[Serum]] [[bicarbonate]] < 18 mEq/L | * [[Serum]] [[bicarbonate]] < 18 mEq/L | ||
* [[Anion gap]] > 10 mEq/L | * [[Anion gap]] > 10 mEq/L | ||
* Increased [[serum]] [[osmolarity]] | * Increased [[serum]] [[osmolarity]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* May have all clinical features of [[diabetes mellitus]] | * May have all clinical features of [[diabetes mellitus]] | ||
* [[Hypotension]] | |||
* [[Tachycardia]] | |||
* [[Dehydration]] | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Younger age with [[Diabetes mellitus type 2|type 1 diabetes mellitus]] | |||
* Prolonged [[hyperglycemia]] | |||
* Undiagnosed [[Diabetes mellitus type 2|type 1 diabetes mellitus]] | |||
* Younger age with [[Diabetes mellitus type 2|type 1 diabetes mellitus]] | |||
* Prolonged [[hyperglycemia]] | |||
* Undiagnosed [[Diabetes mellitus type 2|type 1 diabetes mellitus]] | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 113: | Line 70: | ||
* [[Fasting blood sugar|Fasting blood glucose]] level: 100-125 mg/dl | * [[Fasting blood sugar|Fasting blood glucose]] level: 100-125 mg/dl | ||
* [[Oral glucose tolerance test]]: 140-200 mg/dl | * [[Oral glucose tolerance test]]: 140-200 mg/dl | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* May have all clinical features of [[diabetes mellitus]] | * May have all clinical features of [[diabetes mellitus]] | ||
* [[Obesity]] ([[Body mass index|BMI]] >25 kg/m2) | * [[Obesity]] ([[Body mass index|BMI]] >25 kg/m2) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Family history]] of [[diabetes]] | * [[Family history]] of [[diabetes]] | ||
* [[Sedentary lifestyle]] | * [[Sedentary lifestyle]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|} | |} | ||
Differentiating hyperosmolar hyperglycemic state from [[diabetic ketoacidosis]] (DKA) based on laboratory findings. | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" align="center" | |||
|+ | |+ | ||
! style="background: #4479BA; width: 200px;" | Parameters | ! style="background: #4479BA; width: 200px;" | Parameters | ||
Line 279: | Line 86: | ||
! style="background: #4479BA; width: 300px;" | [[Hyperosmolar hyperglycemic state (HHS)]] | ! style="background: #4479BA; width: 300px;" | [[Hyperosmolar hyperglycemic state (HHS)]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Plasma glucose | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* > 250 mg/dl | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
* > 600 mg/dl | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Serum osmolality | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * Variable | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * > 320 mOsm/kg | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Plasma and urine ketones | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * Positive | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * None or trace | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Serum bicarbonate | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * < 18 mEq/L | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * > 15 mEq/ L | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Arterial ph | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * < 7.30 | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * > 7.30 | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; text-align:center;" |Anion gap | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * > 12 | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * < 12 | ||
|} | |} | ||
Line 315: | Line 128: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Up-To-Date]] | |||
| |||
[[Category:Emergency medicine]] |
Latest revision as of 22:40, 25 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]
Overview
The hyperosmolar hyperglycemic state must be differentiated from other conditions presenting with hyperglycemia, hyperosmolarity or an altered state of consciousness. The differentials include diabetes mellitus, diabetic ketoacidosis, impaired glucose tolerance, and conditions causing altered sensorium such as CNS infections or stroke. All these conditions may be differentiated on the basis of history findings, clinical features, and laboratory abnormalities.
Differentiating Hyperosmolar Hyperglycemic State From Other Diseases
- Hyperosmolar hyperglycemic state must be differentiated from other diseases that present with hyperglycemia, hyperosmolarity, and altered state of consciousness.[1][2][3][4][5][6][7][8]
- Hyperosmolar hyperglycemic state should also be differentiated from conditions that can cause focal neurological signs or an altered state of consciousness such as CNS infections and stroke by doing a simple finger stick glucose testing.
Diseases | Laboratory Findings | Physical Examination | History and Symptoms | Other Findings |
---|---|---|---|---|
Diabetes mellitus |
|
|
||
Diabetic ketoacidosis |
|
|
|
|
Impaired glucose tolerance |
|
|
Differentiating hyperosmolar hyperglycemic state from diabetic ketoacidosis (DKA) based on laboratory findings.
Parameters | Diabetic ketoacidosis (DKA) | Hyperosmolar hyperglycemic state (HHS) |
---|---|---|
Plasma glucose |
|
|
Serum osmolality |
|
|
Plasma and urine ketones |
|
|
Serum bicarbonate |
|
|
Arterial ph |
|
|
Anion gap |
|
|
References
- ↑ "Diabetic Ketoacidosis: Evaluation and Treatment - American Family Physician".
- ↑ Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN (2009). "Hyperglycemic crises in adult patients with diabetes". Diabetes Care. 32 (7): 1335–43. doi:10.2337/dc09-9032. PMC 2699725. PMID 19564476.
- ↑ Chiasson JL, Aris-Jilwan N, Bélanger R, Bertrand S, Beauregard H, Ekoé JM, Fournier H, Havrankova J (2003). "Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state". CMAJ. 168 (7): 859–66. PMC 151994. PMID 12668546.
- ↑ Joseph F, Anderson L, Goenka N, Vora J (2009). "Starvation-induced true diabetic euglycemic ketoacidosis in severe depression". J Gen Intern Med. 24 (1): 129–31. doi:10.1007/s11606-008-0829-0. PMC 2607495. PMID 18975036.
- ↑ Williams HE (1984). "Alcoholic hypoglycemia and ketoacidosis". Med. Clin. North Am. 68 (1): 33–8. PMID 6361416.
- ↑ Durnas C, Cusack BJ (1992). "Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it". Drugs Aging. 2 (1): 20–34. PMID 1554971.
- ↑ Gokel Y, Paydas S, Koseoglu Z, Alparslan N, Seydaoglu G (2000). "Comparison of blood gas and acid-base measurements in arterial and venous blood samples in patients with uremic acidosis and diabetic ketoacidosis in the emergency room". Am. J. Nephrol. 20 (4): 319–23. doi:10.1159/000013607. PMID 10970986.
- ↑ Brinkmann B, Fechner G, Karger B, DuChesne A (1998). "Ketoacidosis and lactic acidosis--frequent causes of death in chronic alcoholics?". Int. J. Legal Med. 111 (3): 115–9. PMID 9587792.